EVERSANA Featured in Fearless in Pharma Virtual Conference

“Embracing scientific advances and novel technologies for leaders and innovators to address unmet needs and drive transformation and disruption in an ever-changing life science industry” is the theme of Fearless in Pharma’s 2021 virtual conference.

During this two-day event, industry leaders will share their personal experiences and authentic stories of innovative and breakthrough thinking to move the needle in the areas of high-performance team execution, R&D advancements, commercial excellence, and entrepreneurial leaps.

On Thursday, June 24, at 12:20 pm EST, EVERSANA’s Ellen Cappellino, RpH, MBA, SVP, Market Access and Patient Services, will be featured in the presentation “Addressing Unmet Medical Needs Through Bold Innovation.

The panel will discuss how today’s mainstay treatments are yesterday’s innovations. “To extend and improve patients’ lives, we have a duty, a responsibility and a desire to transform standards of care and create the innovations of tomorrow.” – Fearless In Pharma 2021

Visit the conference website for more information about the full 2-day event. 


Related Articles

Engaging Oncology Patients and Providers in The Age of COVID And Beyond

The engagement model for oncology patients and providers is failing, and challenges brought on by the COVID-19 pandemic have only accelerated the trend. Not only are pharmaceutical reps restricted in the types of information they are allowed to communicate, but their access to providers in oncology practices is also more limited than ever as a […]

3 Ways Field Teams Can Shape the Market Before and After Product Launch

“It is not how much you have or know, or even who you know; it is how well you adapt to the inevitable changes along the way. As Heraclitus, the Greek philosopher, said, ‘Change is the only constant in life.’” – Marc P. Bernarducci, Senior Vice President of Field Solutions – Clinical Field Medical (FM) […]

Reinventing Launch: The Gold Standard Of Drug Commercialization

In a world that is rapidly changing, we must evolve beyond traditional strategies to create true impact for patients. EVERSANA’s complete end-to-end commercialization model enables manufacturers to bring their drug to market at a fraction of the cost of “going it alone” or partnering with another pharmaceutical company.